China Avatrombopag maleate Manufacturers Factory Suppliers
-
Avatrombopag Maleate- Thrombocytopenia, CAS No.: 677007-74-8
Avatrombopag maleate is a prescription medicine used to treat the symptoms of Thrombocytopenia (lack of platelets in the blood).
-
Daratumumab - Multiple Myeloma (CD-38 Mab), CAS No.: 945721-28-8
As the former gene engineering research center of Huadong Medicine Group, Jiuyuan is the earliest biopharmaceutical company realizing the industrialization of gene engineering in China and is known
-
Dulaglutide - Diabetes (recombinant Route), Diabetes Bulk , CAS No.: 923950-08-7
DULAGLUTIDE contains dulaglutide, a human GLP-1 receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1
-
PegFilgrastim– A Long Lasting RhG-CSF, CAS No.: 208265-92-3,Bulk
Pegfilgrastim (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection
-
Fosaprepitant Dimeglumine, CAS No.: 265121-04-8,Bulk
Fosaprepitant dimeglumine for injection is a sterile, lyophilized formulation containing fosaprepitant dimeglumine, a prodrug of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist
-
Bone Repair Material With RhBMP-2 - Bone Repair,CAS: 64421-28-9
Based on the simultaneous development of innovative drugs and generic drugs, the company focuses on the development of recombinant proteins, antibodies, and combination products of biological and
-
Romosozumab - Osteoporosis, CAS: 909395-70-6
Name: Romosozumab injection . Sclerostin inhibitor. INDICATIONS: Osteoporosis
-
Liraglutide (recombinant Route), Diabetes Bulk, CAS No.: 204656-20-2
Liraglutide is a prescription medicine used to treat the symptoms of Type 2 Diabetes Mellitus. Liraglutide may be used alone or with other medications.
-
Palonosetron Hydrochloride– Anti-emesis After Chemotherapy Or Radiotherapy, CAS No.: 135729-62-3
Generic Name: Palonosetron Hydrochloride injection. The quality and efficacy consistency of generic drugs were evaluated.. The second generation 5-HT3 receptor antagonist, super antagonistic, long -
-
RhG-CSF (Filgrastim) (Recombinant Human Granulocyte Colony-Stimulating Factor) – A Drug To Increase White Blood Cell Count, CAS No.: 121181-53-1
Generic Name: Filgrastim. Chemical Name: Human Granulocyte-Colony Stimulating Factor (hG-CSF) Injection. The first human granulocyte stimulating factor in China; Approved by German GMP international
-
RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material, Registered As An Implanted Medical Device, API
Chemical Name: Recombinant Human Bone Morphogenetic Protein-2. A new type bone repairing material which has biological activity..
-
Enoxaparin Sodium – Anticoagulant and Antithrombotic, CAS No.: 679809-58-6
● The only LWMH is recommended by ACC, ESC and CSC to cure UA and NSTEMI.. ● The only LWMH is approved to cure STEMI.. ● The only enoxaparin sodium which complies with EP 8.0 standard, and has EU and
Avatrombopag maleate Drug Entry Avatrombopag Avatrombopag ( Doptelet ), is an orally administered, small-molecule thrombopoietin receptor (c-Mpl) agonist which increases platelet number, but not...
Avatrombopag maleate (Doptelet; Dova Pharmaceuticals) is an oral, small-molecule second-generation thrombopoietin (TPO) receptor agonist under development for the treatment of...
Avatrombopag maleate pound 93% pound(c) | C33H38Cl2N6O7S2 | CID 134715627 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities,...
Order Avatrombopag Maleate product with CAS: 677007-74-8 and speed up your Avatrombopag project. This product is also known as 1- (3-Chloro-5- ( (4- (4-chlorothiophen-2-yl)-5-...
AVATROMBOPAG MALEATE [WHO-DD] Sources: Common Name English Classification Tree Code System Code; Source: FDA ORPHAN DRUG 699419. Created by admin on Sat Jun 26 08:11:38 UTC 2021, Edited by admin on...
Jun 07, 2021 · Avatrombopag is effective and safe in raising platelet count in patients with chronic liver disease. In addition, it has the characteristics of no risk of neutralizing antibody...
